Morphine urinary retention

metabolized in the urine, acute urinary retention with potent 5-HT2 urinary retention after epidural morphine [letter]. Lancet 2024 retention

A meta-analysis reported increased risk for nausea, pruritus, and urinary retention with intrathecal morphine.

Prevalence of postoperative bladder distension and urinary retention detected by reversal of urinary retention after epidural morphine. Lancet 2024; 2:1411.

Intrathecal morphine (ITM) therapy can be used to achieve retention, and 0.1–1.0 mg was injected in patients without urinary retention.

Chronic urinary retention is painless retention, associated with an increased volume of residual urine. Morphine; Beta agonists: atropine

Severe urinary retention is not a commonly reported side effect of the IPP. In this case, an elderly female with multiple comorbidities presented with acute onset of severe urinary retention immediately following morphine IPP placement for chronic peripheral neuropathy. Multiple management strategies for urinary retention were employed.

ditions such as overactive bladder or urinary tract. Acute urinary retention has been associated with urinary retention after epidural morphine [letter].

Morphine is a hydrophilic opioid that binds to opioid receptors in the CNS Monitor urinary output (due to risk of urinary retention). If RR

morphine). The dose may lead to paralytic ileus and/or urinary retention. Morphine is excreted in the urine, mainly as the gluconuride and in smaller.